Dow Down 0.17% Nasdaq Down 0.28%

More On BLRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BioLineRx, Ltd. (BLRX)

-NasdaqCM
1.54 0.02(1.32%) Sep 30, 3:59PM EDT
Prev Close:1.52
Open:1.53
Bid:1.47 x 3600
Ask:1.60 x 2400
1y Target Est:7.33
Beta:3.09
Next Earnings Date:N/A
Day's Range:1.51 - 1.55
52wk Range:1.45 - 3.34
Volume:23,965
Avg Vol (3m):84,681
Market Cap:52.54M
P/E (ttm):N/A
EPS (ttm):-0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BLRX

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback